Patent ID: 9422303
Filing Date: 2016-08-23
CPC Classification: A61K,A61P,C07D

Claim Text:
1. A method for inhibiting the growth of cancer in an individual comprising administering to the individual a pharmaceutical preparation comprising 0.125-0.5% hydroxypropyl-β-cyclodextrin, 5%-10% dimethyl sulfoxide, and an effective amount of 10H-1,3-Dioxolo[4,5-g]pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-8,11(7H,12H)-dione, 7-ethyl-7-hydroxy-, (S)- (“FL118”), wherein the effective amount of FL118 is 0.25 mg/ml-5.0 mg/ml, such that growth of the cancer in the individual is inhibited subsequent to the administration.